Stock Analysis

Is Now An Opportune Moment To Examine Solvay SA (EBR:SOLB)?

ENXTBR:SOLB
Source: Shutterstock

While Solvay SA (EBR:SOLB) might not be the most widely known stock at the moment, it saw significant share price movement during recent months on the ENXTBR, rising to highs of €94.74 and falling to the lows of €74.82. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Solvay's current trading price of €80.18 reflective of the actual value of the mid-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Solvay’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

Check out our latest analysis for Solvay

Is Solvay Still Cheap?

According to my valuation model, Solvay seems to be fairly priced at around 7.1% below my intrinsic value, which means if you buy Solvay today, you’d be paying a reasonable price for it. And if you believe that the stock is really worth €86.28, then there’s not much of an upside to gain from mispricing. So, is there another chance to buy low in the future? Given that Solvay’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us an opportunity to buy later on. This is based on its high beta, which is a good indicator for share price volatility.

What does the future of Solvay look like?

earnings-and-revenue-growth
ENXTBR:SOLB Earnings and Revenue Growth July 28th 2022

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. However, with a negative profit growth of -13% expected over the next couple of years, near-term growth certainly doesn’t appear to be a driver for a buy decision for Solvay. This certainty tips the risk-return scale towards higher risk.

What This Means For You

Are you a shareholder? SOLB seems fairly priced right now, but given the uncertainty from negative returns in the future, this could be the right time to reduce the risk in your portfolio. Is your current exposure to the stock beneficial for your total portfolio? And is the opportunity cost of holding a negative-outlook stock too high? Before you make a decision on the stock, take a look at whether its fundamentals have changed.

Are you a potential investor? If you’ve been keeping an eye on SOLB for a while, now may not be the most advantageous time to buy, given it is trading around its fair value. The price seems to be trading at fair value, which means there’s less benefit from mispricing. In addition to this, the negative growth outlook increases the risk of holding the stock. However, there are also other important factors we haven’t considered today, which can help crystalize your views on SOLB should the price fluctuate below its true value.

It can be quite valuable to consider what analysts expect for Solvay from their most recent forecasts. Luckily, you can check out what analysts are forecasting by clicking here.

If you are no longer interested in Solvay, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.